Viking Therapeutics Unusual Options Activity For September 11
Viking Therapeutics Unusual Options Activity For September 11
Investors with a lot of money to spend have taken a bullish stance on Viking Therapeutics (NASDAQ:VKTX).
有大量資金可以花的投資者對Viking Therapeutics（納斯達克股票代碼：VKTX）採取了看漲立場。
And retail traders should know.
零售交易者應該知道。
We noticed this today when the positions showed up on publicly available options history that we track here at Benzinga.
今天，當我們在本辛加追蹤的公開期權歷史記錄中出現頭寸時，我們注意到了這一點。
Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with VKTX, it often means somebody knows something is about to happen.
無論這些是機構還是僅僅是富人，我們都不知道。但是，當 VKTX 發生這麼大的事情時，通常意味着有人知道某件事即將發生。
Today, Benzinga's options scanner spotted 25 options trades for Viking Therapeutics.
今天，Benzinga的期權掃描儀發現了Viking Therapeutics的25筆期權交易。
This isn't normal.
這不正常。
The overall sentiment of these big-money traders is split between 60% bullish and 40%, bearish.
這些大手交易者的整體情緒分爲60％看漲和40％（看跌）。
Out of all of the options we uncovered, there was 1 put, for a total amount of $88,413, and 24, calls, for a total amount of $1,052,698.
在我們發現的所有期權中，有1個看跌期權，總額爲88,413美元，還有24個看漲期權，總額爲1,052,698美元。
Projected Price Targets
預計價格目標
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $50.0 and $120.0 for Viking Therapeutics, spanning the last three months.
在評估了交易量和未平倉合約之後，很明顯，主要市場走勢者將注意力集中在Viking Therapeutics在過去三個月的50.0美元至120.0美元之間的價格區間上。
Insights into Volume & Open Interest
對交易量和未平倉合約的見解
Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.
查看交易量和未平倉合約是一種對股票進行盡職調查的有見地的方法。
This data can help you track the liquidity and interest for Viking Therapeutics's options for a given strike price.
這些數據可以幫助您跟蹤Viking Therapeutics期權在給定行使價下的流動性和利息。
Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Viking Therapeutics's whale activity within a strike price range from $50.0 to $120.0 in the last 30 days.
下面，我們可以分別觀察過去30天在行使價範圍內的Viking Therapeutics所有鯨魚活動的看漲和看跌期權交易量和未平倉合約的變化。
Viking Therapeutics Call and Put Volume: 30-Day Overview
Viking Therapeutics 看漲和看跌交易量：30 天概述
Biggest Options Spotted:
發現的最大選擇：
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|---|---|---|
| VKTX | PUT | SWEEP | BULLISH | 01/17/25 | $13.3 | $13.0 | $13.0 | $60.00 | $88.4K | 442 | 86 |
| VKTX | CALL | TRADE | BULLISH | 01/17/25 | $13.0 | $12.4 | $12.8 | $60.00 | $64.0K | 918 | 98 |
| VKTX | CALL | SWEEP | BEARISH | 02/21/25 | $18.2 | $17.8 | $17.8 | $50.00 | $62.3K | 242 | 86 |
| VKTX | CALL | SWEEP | BULLISH | 02/21/25 | $17.5 | $16.6 | $17.05 | $50.00 | $60.9K | 242 | 36 |
| VKTX | CALL | TRADE | BEARISH | 02/21/25 | $11.6 | $11.0 | $11.1 | $70.00 | $59.9K | 387 | 147 |
| 符號 | 看跌/看漲 | 交易類型 | 情緒 | Exp。日期 | 問 | 出價 | 價格 | 行使價 | 總交易價格 | 未平倉合約 | 音量 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| VKTX | 放 | 掃 | 看漲 | 01/17/25 | 13.3 美元 | 13.0 美元 | 13.0 美元 | 60.00 美元 | 88.4 萬美元 | 442 | 86 |
| VKTX | 打電話 | 貿易 | 看漲 | 01/17/25 | 13.0 美元 | 12.4 美元 | 12.8 美元 | 60.00 美元 | 64.0 萬美元 | 918 | 98 |
| VKTX | 打電話 | 掃 | 粗魯的 | 02/21/25 | 18.2 美元 | 17.8 美元 | 17.8 美元 | 50.00 美元 | 62.3 萬美元 | 242 | 86 |
| VKTX | 打電話 | 掃 | 看漲 | 02/21/25 | 17.5 美元 | 16.6 美元 | 17.05 美元 | 50.00 美元 | 60.9 萬美元 | 242 | 36 |
| VKTX | 打電話 | 貿易 | 粗魯的 | 02/21/25 | 11.6 | 11.0 美元 | 11.1 | 70.00 美元 | 59.9 萬美元 | 387 | 147 |
About Viking Therapeutics
關於維京療法
Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.
Viking Therapeutics Inc是一家醫療保健服務提供商。該公司專門從事以代謝和內分泌失調爲重點的生物藥品開發領域。該公司的臨床項目管道包括 VK2809、VK5211、VK0214 產品。VK2809 和 VK0214 是可口服的甲狀腺激素受體 β 的組織和受體亞型選擇性激動劑。VK5211 是一種口服的非甾體選擇性雄激素受體調節劑。
In light of the recent options history for Viking Therapeutics, it's now appropriate to focus on the company itself. We aim to explore its current performance.
鑑於Viking Therapeutics最近的期權歷史，現在應該將重點放在公司本身上。我們的目標是探索其目前的表現。
Current Position of Viking Therapeutics
維京療法的現狀
- With a trading volume of 3,569,240, the price of VKTX is up by 4.12%, reaching $56.9.
- Current RSI values indicate that the stock is may be approaching overbought.
- Next earnings report is scheduled for 42 days from now.
- VKTX的交易量爲3569,240美元，價格上漲了4.12％，達到56.9美元。
- 當前的RSI值表明該股可能已接近超買。
- 下一份收益報告定於42天后發佈。
What The Experts Say On Viking Therapeutics
專家對維京療法的看法
1 market experts have recently issued ratings for this stock, with a consensus target price of $80.0.
1位市場專家最近發佈了該股的評級，共識目標價爲80.0美元。
- An analyst from JP Morgan has revised its rating downward to Overweight, adjusting the price target to $80.
- 摩根大通的一位分析師已將其評級下調至增持，將目標股價調整爲80美元。
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
與僅交易股票相比，期權是一種風險更高的資產，但它們具有更高的獲利潛力。嚴肅的期權交易者通過每天自我教育、擴大交易規模、關注多個指標以及密切關注市場來管理這種風險。